María del Mar Trujillo-Martín has a PhD in Chemical Sciences (University of Seville). She is working as a researcher at the Fundaci n Canaria Institute of Health Research of the Canary Islands (FIISC), Tenerife, Spain, and is associated to the Evaluation Service of the Canary Islands Health Service (SESCS)since 2008, where she coordinates the Knowledge Management Group. Her main activity focuses on the
development of Health Technology Assessment (HTA) reports, Clinical Practice Guidelines, and
other clinical decision support tools. In addition, she participates in several competitive research
projects focused on health services and HTA (basically in implementation science). She is a
member of the Spanish Network of Agencies for Health Technology Assessment and Services of
the National Health System (RedETS), of the Research Network on Health Services in Chronic
Diseases (REDISSEC), of the Network for Research on Chronicity, Primary Care, and Health
Promotion (RICAPPS), and the Institute of Biomedical Technologies of University of La Laguna,
Tenerife, Spain.
María del Mar Trujillo-Martín has a PhD in Chemical Sciences (University of Seville). She is working as a researcher at the Fundaci n Canaria Institute of Health Research of the Canary Islands (FIISC), Tenerife, Spain, and is associated to the Evaluation Service of the Canary Islands Health Service (SESCS)since 2008, where she coordinates the Knowledge Management Group. Her main activity focuses on the
development of Health Technology Assessment (HTA) reports, Clinical Practice Guidelines, and
other clinical decision support tools. In addition, she participates in several competitive research
projects focused on health services and HTA (basically in implementation science). She is a
member of the Spanish Network of Agencies for Health Technology Assessment and Services of
the National Health System (RedETS), of the Research Network on Health Services in Chronic
Diseases (REDISSEC), of the Network for Research on Chronicity, Primary Care, and Health
Promotion (RICAPPS), and the Institute of Biomedical Technologies of University of La Laguna,
Tenerife, Spain.